Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10554-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Yuehong Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Pharmacology, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Pyroptosis, Atherosclerosis, Cholesterol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Health Research Project of Hunan Provincial Health Commission, Scientific Research Fund of Hunan Provincial Education Department.
Abstract (Originalsprache)
Funding Pyroptosis is a type of programmed cell death (PCD) pathway distinguished by inflammation. It is activated by specific inflammasomes. Once activated, it causes the physical breakdown of the cell, along with the discharge of pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18). Abundant evidence has demonstrated the existence of pyroptotic cell death within atherosclerotic plaques, which has significance for the development of atherosclerosis (AS). As a result, pyroptosis has become a new and important topic in cardiovascular disease (CVD) research. Cholesterol, it is recognized to have a connection with inflammation, exerts a crucial function in the development process of AS, and has been linked to the initiation of pyroptosis. This review aims to briefly summarize the fundamental aspects of pyroptosis and the influence of cholesterol-related inflammation in AS. Additionally, this review will explore potential therapeutic approaches based on pyroptosis that could be utilized for the prevention and treatment of AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy and Pharmacology, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Department of Gynecology and Obstetrics, First Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China.
- Institute of Pharmacy and Pharmacology, Hengyang Medical School, University of South China, Hengyang, Hunan, China. sunshaowei2004@aliyun.com.
Förderung
- Health Research Project of Hunan Provincial Health Commission
- Scientific Research Fund of Hunan Provincial Education Department
Zitieren
APA
Tang, Y., Tong, W., Peng, Y., & Sun, S. (2025). Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10554-8
Vancouver
Tang Y, Tong W, Peng Y, Sun S. Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10554-8
BibTeX
@article{Tang2025,
author = {Tang, Yuehong and Tong, Wenjuan and Peng, Yujiao and Sun, Shaowei},
title = {Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10554-8}
}
EUVIMED